| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing adapalene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adapalene (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely adapalene 1 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adapalene (substance) |
Inferred relationship |
Some |
|
| Product containing precisely adapalene 1 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adapalene (substance) |
Inferred relationship |
Some |
|
| adapalen 0,1 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adapalene (substance) |
Inferred relationship |
Some |
|
| adapalen 0,1 % gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adapalene (substance) |
Inferred relationship |
Some |
|
| Adapalene 3 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adapalene (substance) |
Inferred relationship |
Some |
|
| Product containing adapalene and benzoyl peroxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adapalene (substance) |
Inferred relationship |
Some |
1 |
| Adapalene 1 mg/g and benzoyl peroxide 25 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adapalene (substance) |
Inferred relationship |
Some |
|
| Adapalene 0.1% lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adapalene (substance) |
Inferred relationship |
Some |
|
| Product containing precisely adapalene 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adapalene (substance) |
Inferred relationship |
Some |
|
| Adapalene 1 mg/mL cutaneous lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Adapalene (substance) |
Inferred relationship |
Some |
|
| Product containing precisely adapalene 1 milligram/1 gram conventional release cutaneous gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Adapalene (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely adapalene 1 milligram/1 gram conventional release cutaneous gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Adapalene (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely adapalene 1 milligram/1 gram conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Adapalene (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely adapalene 1 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Adapalene (substance) |
Inferred relationship |
Some |
1 |
| Adapalene 1 mg/g and benzoyl peroxide 25 mg/g cutaneous gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Adapalene (substance) |
Inferred relationship |
Some |
2 |
| Adapalene 1 mg/g and benzoyl peroxide 25 mg/g cutaneous gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Adapalene (substance) |
Inferred relationship |
Some |
2 |
| Adapalene- and benzoyl peroxide-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adapalene (substance) |
Inferred relationship |
Some |
1 |
| Product containing adapalene in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adapalene (substance) |
Inferred relationship |
Some |
1 |
| Product containing only adapalene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adapalene (substance) |
Inferred relationship |
Some |
1 |
| Product containing only adapalene and benzoyl peroxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adapalene (substance) |
Inferred relationship |
Some |
1 |
| Product containing only adapalene and benzoyl peroxide in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adapalene (substance) |
Inferred relationship |
Some |
1 |
| Product containing only adapalene in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Adapalene (substance) |
Inferred relationship |
Some |
1 |
| adapalen 0,1 % gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Adapalene (substance) |
Inferred relationship |
Some |
1 |
| adapalen 0,1 % gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Adapalene (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely adapalene 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Adapalene (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely adapalene 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Adapalene (substance) |
Inferred relationship |
Some |
1 |
| Adapalene 3 mg/g cutaneous gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Adapalene (substance) |
Inferred relationship |
Some |
1 |
| Adapalene 3 mg/g cutaneous gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Adapalene (substance) |
Inferred relationship |
Some |
1 |
| Adapalene 1 mg/mL cutaneous lotion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Adapalene (substance) |
Inferred relationship |
Some |
1 |
| Adapalene 1 mg/mL cutaneous lotion |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Adapalene (substance) |
Inferred relationship |
Some |
1 |
| Adapalene 1 mg/g and benzoyl peroxide 25 mg/g cutaneous gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Adapalene (substance) |
Inferred relationship |
Some |
1 |
| Adapalene 1 mg/g and benzoyl peroxide 25 mg/g cutaneous gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Adapalene (substance) |
Inferred relationship |
Some |
1 |
FHIR